BioSpace News Archive

Pharm Country

Cigna Corporation Announces Appearance at the 43rd Annual Cowen Health Care Conference

Global health services company Cigna Corporation (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the 43rd Annual Cowen Health Care Conference on March 6, 2023 in Boston, MA.

February 9, 2023

·

1 min read

Business

NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”) will host a conference call to discuss financial results for its fiscal first quarter 2023 ended December 31, 2022 and provide a corporate update on February 14, 2023 at 4:30 PM Eastern Time.

February 9, 2023

·

1 min read

Biotech Bay

Halle Berry, Long-Standing Pendulum Customer, Joins Company as Chief Communications Officer, and Becomes Equity Owner and Investor

Pendulum Therapeutics announced that Halle Berry, Academy Award® winning actress and director, has joined the company as equity owner, investor and Chief Communications Officer.

February 9, 2023

·

4 min read

Awakn Life Sciences Initiates Feasibility Study for MDMA Using Catalent’s Zydis Orally Disintegrating Tablet (ODT) Technology

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

February 9, 2023

·

5 min read

Biotech Bay

Mirum Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the SVB Securities Global Biopharma Conference.

February 9, 2023

·

1 min read

BioAro is the first Canadian company to launch comprehensive genetic testing panels for various heart diseases

Cardiovascular diseases affects over 3 million Canadians, and over 750, 000 Canadians are living with heart failure.

February 9, 2023

·

5 min read

Business

UPDATE - RadNet, Inc. Announces Date of its Fourth Quarter 2022 Financial Results Conference Call

RadNet, Inc. announced that it will host a conference call to discuss its fourth quarter 2022 financial results on Tuesday, February 28, 2023 at 7:30 a.m. Pacific Time.

February 9, 2023

·

1 min read

aptaTargets’ ApTOLL reduces mortality from 18% to 5% in a Phase 1b/2a trial in ischemic stroke patients

The drug ApTOLL, developed by the biopharmaceutical company aptaTargets, yielded groundbreaking safety and efficacy results in a Phase 1b/2a clinical trial in patients with acute ischemic stroke in combination with endovascular therapy (EVT).

February 9, 2023

·

5 min read

BioMidwest

Eurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day Results

Eurofins Genomics US, the global leader in sequencing, launches a revolutionary new, low cost, whole plasmid sequencing service with same-day results.

February 9, 2023

·

2 min read

Biotech Beach

Palette Life Sciences Announces Publication of Barrigel® Pivotal Safety and Efficacy Clinical Trial Data in JAMA Oncology

Palette Life Sciences announced the publication of the Barrigel® Pivotal Trial, the first U.S. Food and Drug Administration -reviewed randomized controlled study of rectal spacing using hypofractionated radiation therapy, in the prestigous JAMA Oncology.

February 9, 2023

·

5 min read